Molecular genetic testing does not improve the detection of fluoroquinolone resistance before transrectal prostate biopsy

Molecular genetic testing does not improve the detection of fluoroquinolone resistance before transrectal prostate biopsy

Background: Fluoroquinolone-resistant (FQR) Escherichia coli (E. coli) causes transrectal prostate biopsy infections. We seek to further identify fluoroquinolones resistance by the incorporation of genetic profiling to influence antibiotic selection for transrectal prostate biopsy and whether the ad...

Full description

Bibliographic Details
Main Authors: Michael A. Liss, Harshit Garg, Evgeni V. Sokurenko, Jan E. Patterson, Brian L. Wickes
Format: Article
Language:English
Published: Elsevier 2022-12-01
Series:Prostate International
Subjects:
Biopsy
Hospital-acquired infection
Infection
Microbiome
Prostate
Online Access:http://www.sciencedirect.com/science/article/pii/S2287888222000393

Internet

http://www.sciencedirect.com/science/article/pii/S2287888222000393

Similar Items